COVID-19 Funding Snapshot for Pharma Developers/Manufacturers

Views as of August 7, 2020

Cassie Guo

Adam-Nover

Pharma Developers/Manufacturers

COVID-19 pharmaceutical funding landscape

COVID-19 funding has predominantly

COVID-19 drug development

U.S. funding is spread across

government vaccine supply deals

Though funding appears

Select funding deals across

US public deals with disclosed

US public deals with disclosed

Ex-US public deals

with disclosed values

Foundation deals with disclosed

Industry deals with disclosed

COVID-19 funding deals disclaimer

Contributing authors:

Tony Stripling, Associate Consultant
Sean Saunders, Life Sciences Speciaist
Jennifer Henry, Associate Consultant
Patrick Marquet, Associate

Related Insights

Life Sciences & Pharma

Executive Insights

European Drug Pricing and Market Access in a COVID-19 World

October 14, 2020

On 3 June 2020, Médecins Sans Frontières (MSF) issued an appeal urging world leaders to ensure that pharmaceutical companies sell any COVID-19 vaccines at…

Organization & Performance

Executive Insights

Back to Work? Post-COVID-19 Remote Working Approaches Reveal the Adoption of Some…

September 18, 2020

As both employers and employees are increasingly encouraged to “go back to work”, early evidence indicates a wide range of post-COVID-19 flexible and…

Life Sciences & Pharma

Published Articles

Rethinking the Customer Engagement Model in Japan for COVID-19 and Beyond

January 28, 2021

Unlike many other markets in the world, Japan had until very recently been driven by ‘share-of-voice’, with market development and patient share being…

Life Sciences & Pharma

Video / Webinar

How Have Hospitals Across APAC Adapted to the Impact of COVID-19?

April 8, 2021

L.E.K. Consulting’s survey of hospital executives at private and public hospitals in the Asia Pacific region reveals three key themes.

MedTech

Executive Insights

Impact of COVID-19 on the Australian MTP Sector

August 21, 2020

The COVID-19 crisis has had a strongly negative impact on the MTP sector, as it has on many other parts of the Australian economy.

Life Sciences & Pharma

Presentations

2021 Asia-Pacific (APAC) Digital Readiness for the Healthcare Sector

February 26, 2021

The digital health landscape is transforming rapidly; L.E.K. Consulting and Galen Growth evaluated APAC countries.